Chenwei Pan

1.3k total citations
36 papers, 1.0k citations indexed

About

Chenwei Pan is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Chenwei Pan has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Epidemiology and 9 papers in Cancer Research. Recurrent topics in Chenwei Pan's work include Liver Disease Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Chenwei Pan is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Chenwei Pan collaborates with scholars based in China, United States and Nigeria. Chenwei Pan's co-authors include Lingxiang Jin, Zhenzhen Pan, Guangyao Zhou, Wei Lin, Changlong Xu, Peipei Fang, Yi Zheng, Weilai Chen, Keqing Shi and Yi Zheng and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Chenwei Pan

34 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenwei Pan China 18 554 334 197 102 101 36 1.0k
Xuelian Zhao China 17 662 1.2× 470 1.4× 161 0.8× 105 1.0× 69 0.7× 41 1.3k
Hyun Mi Choi South Korea 13 309 0.6× 130 0.4× 229 1.2× 116 1.1× 93 0.9× 26 982
Eliana Guerriero Italy 21 472 0.9× 150 0.4× 197 1.0× 121 1.2× 146 1.4× 35 1.2k
Norimasa Miura Japan 15 385 0.7× 201 0.6× 149 0.8× 75 0.7× 45 0.4× 40 949
Yin‐Kwan Wong China 13 505 0.9× 132 0.4× 113 0.6× 31 0.3× 95 0.9× 28 965
Shuang Ren China 13 364 0.7× 87 0.3× 104 0.5× 74 0.7× 82 0.8× 32 757
Xiaoqin Wu China 19 457 0.8× 103 0.3× 394 2.0× 139 1.4× 145 1.4× 53 1.1k
Xiaohan Zhai China 16 362 0.7× 86 0.3× 142 0.7× 61 0.6× 50 0.5× 31 745
Marwa Hassan Egypt 16 317 0.6× 176 0.5× 68 0.3× 64 0.6× 46 0.5× 55 806
Liu Yan-wen China 19 558 1.0× 103 0.3× 154 0.8× 56 0.5× 49 0.5× 87 1.1k

Countries citing papers authored by Chenwei Pan

Since Specialization
Citations

This map shows the geographic impact of Chenwei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenwei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenwei Pan more than expected).

Fields of papers citing papers by Chenwei Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenwei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenwei Pan. The network helps show where Chenwei Pan may publish in the future.

Co-authorship network of co-authors of Chenwei Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Chenwei Pan. A scholar is included among the top collaborators of Chenwei Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenwei Pan. Chenwei Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Gang, et al.. (2025). Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions. Clinical Pharmacology & Therapeutics. 117(6). 1614–1626. 1 indexed citations
2.
3.
Zhou, Yangyang, Yi Xu, Jingjing Xing, et al.. (2025). Integrated single-cell RNA-seq analysis reveals that EZH2 regulates the MIF-CD74 axis to modulate T cell activation and exhaustion in hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 1040–1040.
4.
5.
Chen, Ping, et al.. (2024). Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma. Frontiers in Immunology. 15. 1504948–1504948. 12 indexed citations
6.
Zhao, Zhiguang, et al.. (2024). Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity. Digestive Diseases and Sciences. 69(2). 491–501. 1 indexed citations
7.
Liu, Jieyu, et al.. (2019). Visit-to-visit blood pressure variability is associated with gestational hypertension and pre-eclampsia. Pregnancy Hypertension. 18. 126–131. 13 indexed citations
8.
Zhang, Lingling, Linong Yao, Jie Li, et al.. (2018). Human babesiosis in Southeast China: A case report. International Journal of Infectious Diseases. 68. 36–38. 4 indexed citations
9.
10.
Pan, Chenwei, Zhenzhen Pan, Xiaodong Wang, et al.. (2018). MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer. Cancer Cell International. 18(1). 52–52. 25 indexed citations
11.
Wu, Lili, Chenwei Pan, Xin Wei, et al.. (2018). lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141. Cell Communication and Signaling. 16(1). 47–47. 66 indexed citations
12.
Zheng, Yi, Jie Li, Chenwei Pan, et al.. (2017). HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells. DNA and Cell Biology. 36(6). 490–500. 7 indexed citations
13.
Xu, Changlong, et al.. (2016). Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway. Biochemical and Biophysical Research Communications. 470(2). 397–404. 40 indexed citations
14.
15.
Zhou, Guangyao, Yongxiang Yi, Lingxiang Jin, et al.. (2016). The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats. Biomedicine & Pharmacotherapy. 81. 318–328. 54 indexed citations
16.
Xu, Changlong, Bihuan Cheng, Lingxiang Jin, et al.. (2015). Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy. Tumor Biology. 37(1). 331–339. 26 indexed citations
17.
Pan, Chenwei, Zhenzhen Pan, Guangyao Zhou, et al.. (2015). Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. European Journal of Pharmacology. 770. 85–91. 95 indexed citations
18.
Pan, Chenwei, Guangyao Zhou, Lingxiang Jin, et al.. (2015). Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury. International Immunopharmacology. 26(1). 80–85. 64 indexed citations
19.
Pan, Chenwei, Xiaodong Wang, Weilai Chen, et al.. (2014). Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software. Medical Oncology. 32(1). 359–359. 19 indexed citations
20.
Pan, Chenwei, et al.. (2005). Synthesis of nickel nano-particles by EB irradiation. 23(1). 6–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuelian Zhao Breakdown of academic impact, for papers by Hyun Mi Choi Breakdown of academic impact, for papers by Eliana Guerriero Breakdown of academic impact, for papers by Norimasa Miura Breakdown of academic impact, for papers by Yin‐Kwan Wong Breakdown of academic impact, for papers by Shuang Ren Breakdown of academic impact, for papers by Xiaoqin Wu Breakdown of academic impact, for papers by Xiaohan Zhai Breakdown of academic impact, for papers by Marwa Hassan Breakdown of academic impact, for papers by Liu Yan-wen
Rankless by CCL
2026